# A Trial To Study The Effect Of Lamivudine In Adult Patients Who Suffer From Chronic Hepatitis B Alone

> **NCT00354653** · PHASE4 · COMPLETED · sponsor: **ViiV Healthcare** · enrollment: 100 (—)

## Conditions studied

- CHRONIC HEPATITIS B

## Interventions

- **DRUG:** LAMIVUDINE

## Key facts

- **NCT ID:** NCT00354653
- **Lead sponsor:** ViiV Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-02-09
- **Primary completion:** 2007-01-23
- **Final completion:** 2007-01-23
- **Target enrollment:** 100 (—)
- **Last updated:** 2020-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00354653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00354653, "A Trial To Study The Effect Of Lamivudine In Adult Patients Who Suffer From Chronic Hepatitis B Alone". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00354653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*